These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 12897739)

  • 1. The effects of an anti-CD11a mAb, efalizumab, on allergen-induced airway responses and airway inflammation in subjects with atopic asthma.
    Gauvreau GM; Becker AB; Boulet LP; Chakir J; Fick RB; Greene WL; Killian KJ; O'byrne PM; Reid JK; Cockcroft DW
    J Allergy Clin Immunol; 2003 Aug; 112(2):331-8. PubMed ID: 12897739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of montelukast (MK-0476), a cysteinyl leukotriene receptor antagonist, on allergen-induced airway responses and sputum cell counts in asthma.
    Diamant Z; Grootendorst DC; Veselic-Charvat M; Timmers MC; De Smet M; Leff JA; Seidenberg BC; Zwinderman AH; Peszek I; Sterk PJ
    Clin Exp Allergy; 1999 Jan; 29(1):42-51. PubMed ID: 10051701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of regular inhaled albuterol on allergen-induced late responses and sputum eosinophils in asthmatic subjects.
    Gauvreau GM; Jordana M; Watson RM; Cockroft DW; O'Byrne PM
    Am J Respir Crit Care Med; 1997 Dec; 156(6):1738-45. PubMed ID: 9412549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison between allergen-induced and exercise-induced asthma with respect to the late asthmatic response, airway responsiveness, and Creola bodies in sputum.
    Tateishi K; Motojima S; Kushima A; Fukuda T; Makino S
    Ann Allergy Asthma Immunol; 1996 Sep; 77(3):229-37. PubMed ID: 8814050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of a single dose of salmeterol on the increase in airway eosinophils induced by allergen challenge in asthmatic subjects.
    Dente FL; Bancalari L; Bacci E; Bartoli ML; Carnevali S; Cianchetti S; Di Franco A; Giannini D; Vagaggini B; Testi R; Paggiaro PL
    Thorax; 1999 Jul; 54(7):622-4. PubMed ID: 10377209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of interleukin-13 blockade on allergen-induced airway responses in mild atopic asthma.
    Gauvreau GM; Boulet LP; Cockcroft DW; Fitzgerald JM; Carlsten C; Davis BE; Deschesnes F; Duong M; Durn BL; Howie KJ; Hui L; Kasaian MT; Killian KJ; Strinich TX; Watson RM; Y N; Zhou S; Raible D; O'Byrne PM
    Am J Respir Crit Care Med; 2011 Apr; 183(8):1007-14. PubMed ID: 21057005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formoterol compared with beclomethasone and placebo on allergen-induced asthmatic responses.
    Wong BJ; Dolovich J; Ramsdale EH; O'Byrne P; Gontovnick L; Denburg JA; Hargreave FE
    Am Rev Respir Dis; 1992 Nov; 146(5 Pt 1):1156-60. PubMed ID: 1443864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. OX40L blockade and allergen-induced airway responses in subjects with mild asthma.
    Gauvreau GM; Boulet LP; Cockcroft DW; FitzGerald JM; Mayers I; Carlsten C; Laviolette M; Killian KJ; Davis BE; Larché M; Kipling C; Dua B; Mosesova S; Putnam W; Zheng Y; Scheerens H; McClintock D; Matthews JG; O'Byrne PM
    Clin Exp Allergy; 2014 Jan; 44(1):29-37. PubMed ID: 24224471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of nasal triamcinolone acetonide on seasonal variations of bronchial hyperresponsiveness and bronchial inflammation in nonasthmatic children with seasonal allergic rhinitis.
    Orhan F; Sekerel BE; Adalioglu G; Pinar M; Tuncer A
    Ann Allergy Asthma Immunol; 2004 Apr; 92(4):438-45. PubMed ID: 15104196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective effects of fluticasone on allergen-induced airway responses and sputum inflammatory markers.
    Parameswaran K; Inman MD; Watson RM; Morris MM; Efthimiadis A; Ventresca PG; Lam R; O'Byrne PM; Hargreave FE
    Can Respir J; 2000; 7(4):313-9. PubMed ID: 10980457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Airway inflammation and altered alveolar macrophage phenotype pattern after repeated low-dose allergen exposure of atopic asthmatic subjects.
    Lensmar C; Prieto J; Dahlén B; Eklund A; Grunewald J; Roquet A
    Clin Exp Allergy; 1999 Dec; 29(12):1632-40. PubMed ID: 10594539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose-dependent effects of inhaled mometasone furoate on airway function and inflammation after allergen inhalation challenge.
    Inman MD; Watson RM; Rerecich T; Gauvreau GM; Lutsky BN; Stryszak P; O'Byrne PM
    Am J Respir Crit Care Med; 2001 Aug; 164(4):569-74. PubMed ID: 11520717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of single-dose inhaled corticosteroid activity with an allergen challenge model.
    Kidney JC; Boulet LP; Hargreave FE; Deschesnes F; Swystun VA; O'Byrne PM; Choudry N; Morris MM; Jennings B; Andersson N; Andreasson A; Cockcroft DW
    J Allergy Clin Immunol; 1997 Jul; 100(1):65-70. PubMed ID: 9257789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mast cell tryptase release and asthmatic responses to allergen increase with regular use of salbutamol.
    Swystun VA; Gordon JR; Davis EB; Zhang X; Cockcroft DW
    J Allergy Clin Immunol; 2000 Jul; 106(1 Pt 1):57-64. PubMed ID: 10887306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attenuation of early and late phase allergen-induced bronchoconstriction in asthmatic subjects by a 5-lipoxygenase activating protein antagonist, BAYx 1005.
    Hamilton AL; Watson RM; Wyile G; O'Byrne PM
    Thorax; 1997 Apr; 52(4):348-54. PubMed ID: 9196518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of MK-0591, a novel 5-lipoxygenase activating protein inhibitor, on leukotriene biosynthesis and allergen-induced airway responses in asthmatic subjects in vivo.
    Diamant Z; Timmers MC; van der Veen H; Friedman BS; De Smet M; Depré M; Hilliard D; Bel EH; Sterk PJ
    J Allergy Clin Immunol; 1995 Jan; 95(1 Pt 1):42-51. PubMed ID: 7822663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel targeted T-cell modulator, efalizumab, for plaque psoriasis.
    Lebwohl M; Tyring SK; Hamilton TK; Toth D; Glazer S; Tawfik NH; Walicke P; Dummer W; Wang X; Garovoy MR; Pariser D;
    N Engl J Med; 2003 Nov; 349(21):2004-13. PubMed ID: 14627785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of IVL745, a VLA-4 antagonist, on allergen-induced bronchoconstriction in patients with asthma.
    Norris V; Choong L; Tran D; Corden Z; Boyce M; Arshad H; Holgate S; O'Connor B; Millet S; Miller B; Rohatagi S; Kirkesseli S
    J Allergy Clin Immunol; 2005 Oct; 116(4):761-7. PubMed ID: 16210048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of an NK1/NK2 receptor antagonist on airway responses and inflammation to allergen in asthma.
    Boot JD; de Haas S; Tarasevych S; Roy C; Wang L; Amin D; Cohen J; Sterk PJ; Miller B; Paccaly A; Burggraaf J; Cohen AF; Diamant Z
    Am J Respir Crit Care Med; 2007 Mar; 175(5):450-7. PubMed ID: 17170385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A dose-dependent effect of the novel inhaled corticosteroid ciclesonide on airway responsiveness to adenosine-5'-monophosphate in asthmatic patients.
    Taylor DA; Jensen MW; Kanabar V; Engelstätter R; Steinijans VW; Barnes PJ; O'Connor BJ
    Am J Respir Crit Care Med; 1999 Jul; 160(1):237-43. PubMed ID: 10390406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.